Can a daily injection and vibration rebuild bones after spinal cord injury?
NCT ID NCT01225055
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a bone-building drug (teriparatide) and a vibrating platform, alone or together, could improve bone density in 60 adults with chronic spinal cord injury who had low bone mass. Participants received daily injections of teriparatide, used a vibration device for 10 minutes a day, or both, for 12 months. The main goal was to see changes in hip bone density measured by DXA scans.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Teriparatide (Forteo) and whole-body vibration
What this could lead to
If successful, this combination could offer a way to strengthen bones and reduce fracture risk in people with chronic spinal cord injury.
What could go wrong
This is a small, early-phase trial with only 60 participants. Results may not apply to everyone, and the treatment requires daily injections and a device, which may be burdensome.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPINAL CORD INJURY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Edward Hines, Jr, VA Hospital
Maywood, Illinois, 60153, United States
-
Northwestern University Feinberg School of Medicine
Chicago, Illinois, 60611, United States